Formulation: A crystalline solid

Purity: ≥95%

Schedule: I

• 4-hydroxy-N,N-Dimethyltryptamine
• 4-hydroxy DMT
• Psilocyn

Formulation: A 1 mg/ml solution in acetonitrile

• 4-hydroxy-N,N-Dimethyltryptamine
• 4-hydroxy DMT
• Psilocyn

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

• 4-hydroxy-N,N-Dimethyltryptamine
• 4-hydroxy DMT
• Psilocyn

Formulation: A crystalline solid

Purity: ≥99% deuterated forms (d₁-d₆)

Schedule: I

• 4-hydroxy-N,N-Dimethyltryptamine-d₆
• 4-hydroxy DMT-d₆

Formulation: A crystalline solid

Purity: ≥99% deuterated forms (d₁-d₁₀)

Schedule: I

• 4-hydroxy DMT-d₁₀
• 4-hydroxy-N,N-Dimethyltryptamine-d₁₀

Formulation: A 100 μg/ml solution in acetonitrile

• 4-hydroxy-N,N-Dimethyltryptamine-d₁₀
• 4-hydroxy DMT-d₁₀

Formulation: A crystalline solid

Purity: ≥98%

• ω-N-methyl-4-Hydroxytryptamine
• 4-hydroxy-N-Methyltryptamine
• 4-hydroxy NMT

Formulation: A 1 mg/ml solution in acetonitrile

• ω-N-methyl-4-Hydroxytryptamine
• 4-hydroxy-N-Methyltryptamine
• 4-hydroxy NMT

Formulation: A solid

Purity: ≥99% deuterated forms (d₁-d₄)

• ω-N-methyl-4-Hydroxytryptamine-d₄
• 4-hydroxy-N-Methyltryptamine-d₄
• 4-hydroxy NMT-d₄

Formulation: A 100 μg/ml solution in acetonitrile

• ω-N-methyl-4-Hydroxytryptamine-d₄
• 4-hydroxy-N-Methyltryptamine-d₄
• 4-hydroxy NMT-d₄

Formulation: A crystalline solid

Purity: ≥98%

• N-desmethyl Psilocybin

Formulation: A 100 µg/ml solution in acetonitrile:water (1:1)

• N,N-desmethyl Psilocybin
• 4-hydroxy Tryptamine Phosphate

Formulation: A crystalline solid

Purity: ≥98%

• 4-phosphoryloxy-N,N,N-Trimethyltryptamine

Formulation: A crystalline solid

Purity: ≥95%

Schedule: I

• 7-hydroxy-N,N-Dimethyltryptamine

Formulation: A crystalline solid

Purity: ≥98%

• N,N-desmethyl Psilocybin
• 4-hydroxy Tryptamine Phosphate

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥99% deuterated forms (d₁-d₆)

Schedule: I

Formulation: A 1 mg/ml solution in acetonitrile:water (1:1)

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

Formulation: A crystalline solid

Purity: ≥98%

• 4-acetoxy-N,N,N-Trimethyltryptamine

Formulation: A crystalline solid

Purity: ≥98%

• 4-hydroxy-N-methyl-N-isopropyl Tryptamine
• 4-OH MiPT

Formulation: A 10 mg/ml solution in acetonitrile

Purity: ≥90%

• 4-acetoxy-N,N-Dimethyltryptamine
• O-Acetylpsilocin
• Psilacetin

Formulation: A crystalline solid

Purity: ≥98%

• 4-hydroxy-N,N,N-Trimethyltryptamine

Formulation: A crystalline solid

Purity: ≥98%

• 4-acetoxy-N,N-Dimethyltryptamine
• O-Acetylpsilocin
• Psilacetin

Formulation: A crystalline solid

Purity: ≥98%

• 4-HIAA
• 41-IIAA
• 4-hydroxy Indole-3-yl-acetic Acid